Patent Assignment
Reel/Frame 048472/0333
Assignment of Assignor's Interest
Recorded: 2019-02-28
Pages: 6
Assignor
ANTECIP BIOVENTURES II LLC
Executed: 2019-02-27
Assignee
AXSOME THERAPEUTICS, INC.
25 BROADWAY, 9TH FLOOR, NEW YORK, NEW YORK, 10004
Covered Properties
(3)
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application:
62/634,718 →
PCT:
PCT/US2019/019445 ↗
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application:
62/794,469 →
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application:
62/809,480 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 23, 2018
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 045883/0732 →
Assignment of Assignor's Interest
Feb 28, 2019
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 048465/0210 →
Security Interest
May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →